Robbie Marcus
Stock Analyst at J.P. Morgan
(4.26)
# 1,440
Out of 4,630 analysts
525
Total ratings
52.7%
Success rate
7%
Average return
Main Sectors:
Stocks Rated by Robbie Marcus
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BAX Baxter International | Maintained: Hold | $19 → $26 | $27.55 | -5.63% | 24 | Aug 6, 2026 | |
| RXST RxSight | Maintained: Sell | $9 → $6 | $6.26 | -4.15% | 19 | Aug 6, 2026 | |
| PODD Insulet | Downgraded: Hold | $275 → $152 | $141.17 | +7.67% | 26 | Aug 5, 2026 | |
| DXCM DexCom | Maintained: Hold | $82 | $84.75 | -3.24% | 27 | Aug 4, 2026 | |
| IART Integra LifeSciences Holdings | Maintained: Sell | $11 → $17 | $17.25 | -1.45% | 21 | Aug 4, 2026 | |
| MMSI Merit Medical Systems | Maintained: Buy | $95 | $89.04 | +6.69% | 6 | Aug 4, 2026 | |
| SYK Stryker | Maintained: Buy | $350 | $339.03 | +3.24% | 19 | Aug 4, 2026 | |
| INSP Inspire Medical Systems | Maintained: Hold | $54 → $60 | $60.16 | -0.27% | 21 | Aug 4, 2026 | |
| BSX Boston Scientific | Rated: Buy | $56 | $49.31 | +13.57% | 28 | Jul 30, 2026 | |
| CNMD CONMED | Rated: Hold | $40 → $45 | $49.12 | -8.39% | 20 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $65 → $70 | $71.77 | -2.47% | 5 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $105 | $89.72 | +17.03% | 25 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $450 | $378.81 | +18.79% | 20 | Jul 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $110 → $120 | $107.81 | +11.31% | 18 | Jul 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $80 → $71 | $74.23 | -4.35% | 20 | Jun 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $86 | $87.16 | -1.33% | 25 | Jun 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $15 | $12.24 | +22.55% | 1 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $6 | $2.39 | +151.05% | 16 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $100 → $95 | $96.55 | -1.61% | 17 | Apr 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $35 | $28.82 | +21.44% | 5 | Mar 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $275 → $370 | $324.66 | +13.97% | 25 | Dec 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $21 → $17 | $18.81 | -9.62% | 5 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $13 → $16 | $16.78 | -4.65% | 13 | Oct 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $37 → $33 | $26.61 | n/a | 5 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $9 → $7 | $6.05 | n/a | 27 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $185 → $190 | $176.86 | n/a | 13 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $13 → $7 | $14.13 | n/a | 8 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $40 → $51 | $41.42 | n/a | 20 | Feb 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $9 → $14 | $14.83 | n/a | 10 | Dec 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $15 → $8 | $4.76 | n/a | 7 | May 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $80 → $85 | $180.02 | n/a | 13 | May 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $95 | $127.84 | n/a | 14 | Apr 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $34 | $83.89 | n/a | 1 | May 28, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $40 | $20.18 | n/a | 1 | Jun 8, 2018 |
Baxter International
Aug 6, 2026
Maintained: Hold
Price Target: $19 → $26
Current: $27.55
Upside: -5.63%
RxSight
Aug 6, 2026
Maintained: Sell
Price Target: $9 → $6
Current: $6.26
Upside: -4.15%
Insulet
Aug 5, 2026
Downgraded: Hold
Price Target: $275 → $152
Current: $141.17
Upside: +7.67%
DexCom
Aug 4, 2026
Maintained: Hold
Price Target: $82
Current: $84.75
Upside: -3.24%
Integra LifeSciences Holdings
Aug 4, 2026
Maintained: Sell
Price Target: $11 → $17
Current: $17.25
Upside: -1.45%
Merit Medical Systems
Aug 4, 2026
Maintained: Buy
Price Target: $95
Current: $89.04
Upside: +6.69%
Stryker
Aug 4, 2026
Maintained: Buy
Price Target: $350
Current: $339.03
Upside: +3.24%
Inspire Medical Systems
Aug 4, 2026
Maintained: Hold
Price Target: $54 → $60
Current: $60.16
Upside: -0.27%
Boston Scientific
Jul 30, 2026
Rated: Buy
Price Target: $56
Current: $49.31
Upside: +13.57%
CONMED
Jul 30, 2026
Rated: Hold
Price Target: $40 → $45
Current: $49.12
Upside: -8.39%
Jul 30, 2026
Rated: Hold
Price Target: $65 → $70
Current: $71.77
Upside: -2.47%
Jul 28, 2026
Maintained: Buy
Price Target: $105
Current: $89.72
Upside: +17.03%
Jul 21, 2026
Maintained: Buy
Price Target: $450
Current: $378.81
Upside: +18.79%
Jul 17, 2026
Maintained: Buy
Price Target: $110 → $120
Current: $107.81
Upside: +11.31%
Jun 5, 2026
Maintained: Hold
Price Target: $80 → $71
Current: $74.23
Upside: -4.35%
Jun 5, 2026
Maintained: Hold
Price Target: $86
Current: $87.16
Upside: -1.33%
Jun 2, 2026
Initiated Coverage: Buy
Price Target: $15
Current: $12.24
Upside: +22.55%
May 12, 2026
Reiterated: Sell
Price Target: $6
Current: $2.39
Upside: +151.05%
Apr 29, 2026
Maintained: Hold
Price Target: $100 → $95
Current: $96.55
Upside: -1.61%
Mar 25, 2026
Maintained: Buy
Price Target: $35
Current: $28.82
Upside: +21.44%
Dec 18, 2025
Upgraded: Buy
Price Target: $275 → $370
Current: $324.66
Upside: +13.97%
Nov 5, 2025
Maintained: Buy
Price Target: $21 → $17
Current: $18.81
Upside: -9.62%
Oct 30, 2025
Maintained: Hold
Price Target: $13 → $16
Current: $16.78
Upside: -4.65%
Aug 8, 2025
Maintained: Hold
Price Target: $37 → $33
Current: $26.61
Upside: n/a
Aug 8, 2025
Maintained: Sell
Price Target: $9 → $7
Current: $6.05
Upside: n/a
Aug 7, 2025
Maintained: Hold
Price Target: $185 → $190
Current: $176.86
Upside: n/a
May 6, 2025
Maintained: Hold
Price Target: $13 → $7
Current: $14.13
Upside: n/a
Feb 11, 2025
Maintained: Buy
Price Target: $40 → $51
Current: $41.42
Upside: n/a
Dec 17, 2024
Initiated Coverage: Buy
Price Target: $9 → $14
Current: $14.83
Upside: n/a
May 8, 2024
Downgraded: Hold
Price Target: $15 → $8
Current: $4.76
Upside: n/a
May 6, 2021
Maintained: Sell
Price Target: $80 → $85
Current: $180.02
Upside: n/a
Apr 12, 2021
Downgraded: Hold
Price Target: $95
Current: $127.84
Upside: n/a
May 28, 2019
Initiated Coverage: Buy
Price Target: $34
Current: $83.89
Upside: n/a
Jun 8, 2018
Upgraded: Buy
Price Target: $40
Current: $20.18
Upside: n/a